Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results

Go back to Fulcrum Therapeutics® Reports Recent Business Highlights and Fourth Quarter and Full Year 2021 Financial Results
(NASDAQ: FULC) Delayed: 3.80 --0 (-0%)
Previous Close $3.80    52 Week High
Open $3.80    52 Week Low
Day High $3.80    P/E N/A 
Day Low $3.80    EPS
Volume 12